Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pediatric radiotherapy. An overview

J A Kalapurakal1, P R Thomas

  • 1Department of Radiation Oncology, Northwestern University, Chicago, Illinois, USA.

Radiologic Clinics of North America
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediodontia.

The Dental register·2021
Same author

Reply.

The Journal of hand surgery, European volume·2015
Same author

Comparison of digital nerve sensory recovery after repair using loupe or operating microscope magnification.

The Journal of hand surgery, European volume·2014
Same author

Vitamin E and selenium levels are within normal range in pigs diagnosed with mulberry heart disease and evidence for viral involvement in the syndrome is lacking.

Transboundary and emerging diseases·2011
Same author

Active control of type-I edge-localized modes with n=1 perturbation fields in the JET tokamak.

Physical review letters·2007
Same author

Motor, visual and egocentric transformations in children with Developmental Coordination Disorder.

Child: care, health and development·2006
Same journal

Orbital Imaging.

Radiologic clinics of North America·2026
Same journal

Imaging, Management, and Treatment of Orbital Trauma.

Radiologic clinics of North America·2026
Same journal

Imaging Findings after Multidisciplinary Treatment for Orbital and Ocular Adnexal Cancers.

Radiologic clinics of North America·2026
Same journal

Orbital Tumors: What the Radiologist Needs to Know from the Orbital Surgeon's Perspective.

Radiologic clinics of North America·2026
Same journal

Multidisciplinary Management of Tumors of the Orbit.

Radiologic clinics of North America·2026
Same journal

Skull Base, Bone, Pituitary-Regions around Orbit that Affect Vision.

Radiologic clinics of North America·2026
See all related articles

Radiotherapy (RT) use in pediatric cancer has evolved, with reduced or modified applications in many diseases. Understanding late effects and secondary malignant neoplasms (SMN) refines treatment strategies and monitoring for improved long-term outcomes.

Area of Science:

  • Pediatric Oncology
  • Radiation Oncology
  • Cancer Genetics

Background:

  • Radiation therapy (RT) applications in pediatric cancers have significantly changed over time.
  • While reduced in some cancers like Non-Hodgkin's lymphoma (NHL) and Acute Lymphoblastic Leukemia (ALL), RT remains crucial for others, especially brain tumors.
  • Increased understanding of RT's long-term effects and the risk of secondary malignant neoplasms (SMN) has prompted treatment modifications.

Purpose of the Study:

  • To review the evolving role of RT in pediatric cancer treatment.
  • To highlight the impact of late effects and SMN on current therapeutic strategies.
  • To emphasize the importance of genetic predisposition and long-term surveillance in pediatric cancer survivors.

Main Methods:

  • Review of current RT utilization across various pediatric malignancies.

Related Experiment Videos

  • Analysis of treatment modifications based on knowledge of late effects and SMN.
  • Discussion of genetic testing (e.g., for RB and p53 mutations) to identify high-risk individuals.
  • Emphasis on long-term follow-up protocols for cancer survivors.

    • Main Results:

    • RT use has been eliminated, reduced, or refined in pediatric cancers such as NHL, Wilms' tumor, ALL, neuroblastoma, rhabdomyosarcoma, and Ewing's sarcoma.
    • Lower RT doses and non-alkylator chemotherapy are now common in Hodgkin's disease to mitigate late effects.
    • DNA testing can identify germline mutations (e.g., RB, p53) predisposing children to SMN, allowing for tailored treatment.
    • Careful monitoring of survivors is essential for early detection and management of late consequences.

    Conclusions:

    • RT remains an important modality in pediatric oncology, particularly for brain tumors.
    • Knowledge of late effects and SMN risk is actively reshaping treatment paradigms.
    • Genetic screening and vigilant long-term surveillance are critical for improving the quality of life and survival rates of pediatric cancer survivors.